• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

BD names new president of medication delivery

October 3, 2022 By Sean Whooley

Eric Borin BD President of Medication Delivery Solutions
Eric Borin. [Image from BD]
BD (NYSE:BDX) announced today that it named Eric Borin as its president of medication delivery solutions (MDS).

Borin, 55, succeeds Rick Byrd in the role. Byrd recently received a promotion to EVP and president of BD’s interventional segment.

As president of medication delivery solutions, Borin will report to Mike Garrison, EVP and president of the BD medical segment. Borin previously served as president of pharmaceutical systems for the Franklin Lakes, New Jersey-based company.

Borin’s responsibilities include driving global strategic, operational and commercial performance of the MDS business unit.

According to a news release, he joined BD in 1996 as a technical service manager in pharmaceutical systems. He held a number of leadership roles from that point. BD named him VP and GM of North America for diabetes care in 2010. Borin then moved to the same role for pharmaceutical systems.

In 2014, Borin earned a promotion to VP and GM of BD Rx, which he led until BD divested it to Fresenius Kabi. Borin rejoined diabetes care as VP and GM of the U.S. region in 2016. He then moved to VP and GM of infusion specialty disposables in 2017. His promotion to president of pharmaceutical systems came in 2020.

“Eric has more than 25 years of BD leadership experience and is well suited to lead MDS — BD’s largest business unit by revenue,” said Garrison. “Over the past two years, Eric has led pharmaceutical systems to become one of the highest growth business units for BD and increased revenue well above BD’s long-term target.

“He has also positioned the business for the future by enabling the development of several innovative new drug delivery platforms to develop transformative solutions for the pharmaceutical industry and patients around the world.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel, Pharmaceuticals Tagged With: BD, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS